The rapid spread of carbapenem-resistant Enterobacteriaceae
- PMID: 27912842
- PMCID: PMC5140036
- DOI: 10.1016/j.drup.2016.09.002
The rapid spread of carbapenem-resistant Enterobacteriaceae
Abstract
Carbapenems, our one-time silver bullet for multidrug resistant bacterial infections, are now threatened by widespread dissemination of carbapenem-resistant Enterobacteriaceae (CRE). Successful expansion of Enterobacteriaceae clonal groups and frequent horizontal gene transfer of carbapenemase expressing plasmids are causing increasing carbapenem resistance. Recent advances in genetic and phenotypic detection facilitate global surveillance of CRE diversity and prevalence. In particular, whole genome sequencing enabled efficient tracking, annotation, and study of genetic elements colocalized with carbapenemase genes on chromosomes and on plasmids. Improved characterization helps detail the co-occurrence of other antibiotic resistance genes in CRE isolates and helps identify pan-drug resistance mechanisms. The novel β-lactamase inhibitor, avibactam, combined with ceftazidime or aztreonam, is a promising CRE treatment compared to current colistin or tigecycline regimens. To halt increasing CRE-associated morbidity and mortality, we must continue quality, cooperative monitoring and urgently investigate novel treatments.
Keywords: Antibiotic resistance; Carbapenem Resistant Enterobacteriaceae; Horizontal gene transfer.
Copyright © 2016 Elsevier Ltd. All rights reserved.
References
-
- Abdul Rahim N, Cheah SE, Johnson MD, Yu H, Sidjabat HE, Boyce J, et al. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two ‘old’ antibiotics-polymyxin B and chloramphenicol. J Antimicrob Chemother. 2015;70(9):2589–2597. http://dx.doi.org/10.1093/jac/dkv135, Epub 2015/05/30. - DOI - PMC - PubMed
-
- Adamczuk M, Zaleski P, Dziewit L, Wolinowska R, Nieckarz M, Wawrzyniak P, et al. Diversity and global distribution of IncL/M plasmids enabling horizontal dissemination of beta-lactam resistance genes among the Enterobacteriaceae. BioMed Res Int. 2015;2015:414681. http://dx.doi.org/10.1155/2015/414681, Epub 2015/08/04. - DOI - PMC - PubMed
-
- Adler A, Ben-Dalak M, Chmelnitsky I, Carmeli Y. Effect of resistance mechanisms on the inoculum effect of carbapenem in Klebsiella pneumoniae isolates with borderline carbapenem resistance. Antimicrob Agents Chemother. 2015a;59(8):5014–5017. http://dx.doi.org/10.1128/AAC.00533-15, Epub 2015/05/20. - DOI - PMC - PubMed
-
- Adler A, Hussein O, Ben-David D, Masarwa S, Navon-Venezia S, Schwaber MJ, et al. Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008–13. J Antimicrob Chemother. 2015b;70(1):89–92. http://dx.doi.org/10.1093/jac/dku333, Epub 2014/09/11. - DOI - PubMed
-
- Adler M, Anjum M, Andersson DI, Sandegren L. Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli. J Antimicrob Chemother. 2016;71(5):1188–1198. http://dx.doi.org/10.1093/jac/dkv475, Epub 2016/02/13. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
